Evidence map›Paper›PMID 36160719›Full record

ArticlePublic health action2022

Assessment of TB underreporting by level of reporting system in Lagos, Nigeria.

M Gidado, E M H Mitchell, A O Adejumo, J Levy, O Emperor, A Lawson, N Chukwueme, H Abdur-Razak, A Idris, A Adebowale

Abstract read
In one paragraph

Article in Public health action, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M GidadoKNCV Tuberculosis Foundation, The Hague, Netherlands.
E M H MitchellDepartment of Public Health, Institute for Tropical Medicine, Antwerp, Belgium.
A O AdejumoMainland Hospital, Yaba, Lagos, Nigeria.
J LevyKNCV Tuberculosis Foundation, The Hague, Netherlands.
O EmperorNational TB & Leprosy Control Program, Abuja, Nigeria.
A LawsonNational TB & Leprosy Control Program, Abuja, Nigeria.
N ChukwuemeNew York Medical College, NY, New York.
H Abdur-RazakHealth Research Unit, Lagos State Ministry of Health, Lagos, Nigeria.
A IdrisLagos State TB and Leprosy Control Program, Lagos State Ministry of Health, Lagos, Nigeria.
A AdebowaleWalden University, Minneapolis, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNigeria has an estimated TB prevalence of 219 per 100,000 population. In 2019, Nigeria diagnosed and notified 27% of the WHO-estimated cases of all forms of TB and contributed 11% of the missing TB cases globally.

objectiveTo assess TB underreporting by type and level of health facility (HF), and associated factors in Lagos State, Nigeria. METHODOLOGY: Quantitative secondary data analysis of TB cases was conducted in 2015. χ

resultsOverall, 2,064 persons with bacteriologically confirmed TB (15.5%) were not matched to patients in sampled TB registers. Treatment status was unknown for 86 cases (IQR 55-97) per LGA. LGAs with higher case-loads had higher proportions of cases with unknown TB status. Discrepant reporting of treated TB was also common (60% HFs). Primary-level TB treatment facilities and unengaged private facilities were less likely to notify.

conclusionThere was TB under-reporting across all types and levels of HFs and LGAs. There is a need to revise or strengthen the process of supervision and data quality assurance system at all levels.

Indexed as

inventory studyNigeriaTB reporting systemTB underreporting

Identifiers

PMID36160719
PMCPMC9484589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.